menu
    • menu

    Company profile for InnoCare Pharma

    NEW Drugs in Dev: 18
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company committed to discovering, developing and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. Led by a world-class management team of seasoned industry executives, we have built a fully integrated biopharmaceutical platform with strong in-house R&D capabilities. Our vision is to become a global biopharmaceutical leader t...
    We are a clinical stage biopharmaceutical company committed to discovering, developing and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. Led by a world-class management team of seasoned industry executives, we have built a fully integrated biopharmaceutical platform with strong in-house R&D capabilities. Our vision is to become a global biopharmaceutical leader that develops anddelivers innovative therapies for patients worldwide. We have built a fully integrated platform that covers the entire spectrum of drug discovery and development functionalities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InnoCare PharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Building 8, No. 8 Life Science Park Road, Zhongguancun Life Science Park, Chan...
    Telephone
    Telephone
    +86 10 66609999
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.innocarepharma.com/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innocare Achieves First Annual Profit In 2025 Results
    Innocare Achieves First Annual Profit In 2025 Results

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262266/0/en/InnoCare-Releases-2025-Results-and-Business-Highlights-Achieving-First-Annual-Profit.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Priority Review for InnoCare's Zurletrectinib in Pediatric Tumors
    Priority Review for InnoCare's Zurletrectinib in Pediatric Tumors

    01 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3246995/0/en/InnoCare-s-next-generation-TRKi-Zurletrectinib-Receives-Priority-Review-for-the-Treatment-of-Pediatric-Patients-with-Solid-Tumors-in-China.html

    GLOBENEWSWIRE
    01 Mar 2026
    Share Share
    Soficitinib Shows Efficacy in Atopic Dermatitis Patients
    Soficitinib Shows Efficacy in Atopic Dermatitis Patients

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3228229/0/en/Study-Results-of-Novel-TYK2-Inhibitor-Soficitinib-in-Patients-with-AD-Published-by-JAMA-Dermatology.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    Innocare Pharma Advances Oral Lupus Drug To Phase II Trial
    Innocare Pharma Advances Oral Lupus Drug To Phase II Trial

    27 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/innocare-pharma-gets-green-light-for-phase-ii-trial-of-oral-lupus-drug-18685

    INDPHARMAPOST
    27 Dec 2025
    Share Share
    Innocare Greenlights Phase II/III Trial For Soficitinib
    Innocare Greenlights Phase II/III Trial For Soficitinib

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207397/0/en/InnoCare-Announces-Approval-of-Phase-II-III-Clinical-Trial-of-Novel-TYK2-Inhibitor-Soficitinib-for-Chronic-Spontaneous-Urticaria-in-China.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    InnoCare's Orelabrutinib Meets Primary Endpoint in Phase 2b SLE
    InnoCare's Orelabrutinib Meets Primary Endpoint in Phase 2b SLE

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205293/0/en/Zenas-BioPharma-s-Partner-InnoCare-Pharma-Announces-Achievement-of-Primary-Endpoint-in-Phase-2b-Study-of-Orelabrutinib-a-BTK-Inhibitor-for-Systemic-Lupus-Erythematosus.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search